IN2013MU02852A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02852A
IN2013MU02852A IN2852MU2013A IN2013MU02852A IN 2013MU02852 A IN2013MU02852 A IN 2013MU02852A IN 2852MU2013 A IN2852MU2013 A IN 2852MU2013A IN 2013MU02852 A IN2013MU02852 A IN 2013MU02852A
Authority
IN
India
Prior art keywords
naloxone
buprenorphine
opioid
patient
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Rajen Dhirubhai Shah
Milind Sakharam Bagul
Original Assignee
Raptim Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raptim Res Ltd filed Critical Raptim Res Ltd
Priority to IN2852MU2013 priority Critical patent/IN2013MU02852A/en
Publication of IN2013MU02852A publication Critical patent/IN2013MU02852A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN2852MU2013 2013-09-02 2013-09-02 IN2013MU02852A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2852MU2013 IN2013MU02852A (pt) 2013-09-02 2013-09-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2852MU2013 IN2013MU02852A (pt) 2013-09-02 2013-09-02

Publications (1)

Publication Number Publication Date
IN2013MU02852A true IN2013MU02852A (pt) 2015-07-10

Family

ID=54396132

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2852MU2013 IN2013MU02852A (pt) 2013-09-02 2013-09-02

Country Status (1)

Country Link
IN (1) IN2013MU02852A (pt)

Similar Documents

Publication Publication Date Title
HK1222122A1 (zh) 選擇性藥物遞送組合物及使用方法
HK1193045A1 (zh) 在癌症如骨髓增殖性腫瘤治療中的帕比司他與魯索利替尼的組合
GB201317005D0 (en) Composition and methods of treatment
HK1210042A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
MX2015008813A (es) Composiciones y metodos para contrarrestar la inhibicion del factor xa.
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
MX2016011744A (es) Soluciones de buprenorfina de liberacion sostenida.
PT3223906T (pt) Métodos e composições para potencializar a ação de analgésicos de opioides usando alcaloides de iboga
PH12016500666A1 (en) Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
HK1223608A1 (zh) 嗎泛和嗎啡喃類似物和其用途
MX2015012650A (es) Metodos para el tratamiento de angioedema mediado receptores debradicinina b2.
EP3061452A4 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
IN2014DN09238A (pt)
ZA201408055B (en) Compositions and methods for the treatment of local pain
EP2983789A4 (en) COMPOSITIONS AND METHODS OF DELIVERING THERAPY AGENTS
MX368870B (es) Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
IL235272B (en) Alfentanil composition for the treatment of acute pain
HK1222543A1 (zh) 經口藥物遞送裝置和其使用方法
EP2968247A4 (en) Taste masking of anesthetics and analgesics
IN2013MU01111A (pt)
TR201803744T4 (tr) Skleroderma tedavisinde kullanım için naltrekson içeren bileşimler.
ZA201506396B (en) Use of sedoheptulose for prevention or treatment of inflammation
IN2013MU02852A (pt)